Page 276 - EJMO-9-2

Eurasian Journal of
Medicine and Oncology ANGPTL8 upregulation in CRC with liver metastasis

by colorectal cancer metastases requires YAP-controlled 25. Zhang R, Abou-Samra AB. A dual role of lipasin (betatrophin)
plasticity at the micrometastatic stage. Cancer Res. in lipid metabolism and glucose homeostasis: consensus and
2022;82(10):1953-1968. controversy. Cardiovasc Diabetol. 2014;13(1):133.
doi: 10.1158/0008-5472.CAN-21-0933 doi: 10.1186/s12933-014-0133-8
15. Fu Z, Berhane F, Fite A, Seyoum B, Abou-Samra AB, 26. Abu-Farha M, Cherian P, Qaddoumi MG, et al. Increased
Zhang R. Elevated circulating lipasin/betatrophin in human plasma and adipose tissue levels of ANGPTL8/Betatrophin
type 2 diabetes and obesity. Sci Rep. 2015;4(1):5013. and ANGPTL4 in people with hypertension. Lipids Health
doi: 10.1038/srep05013 Dis. 2018;17(1):35.
16. Zhang R. The ANGPTL3-4-8 model, a molecular mechanism doi: 10.1186/s12944-018-0681-0
for triglyceride trafficking. Open Biol. 2016;6(4):150272. 27. Liu J, Yagi K, Nohara A, et al. High frequency of type 2
doi: 10.1098/rsob.150272 diabetes and impaired glucose tolerance in Japanese subjects
with the angiopoietin-like protein 8 R59W variant. J Clin
17. Gao T, Jin K, Chen P, et al. Circulating betatrophin correlates Lipidol. 2018;12(2):331-337.
with triglycerides and postprandial glucose among different
glucose tolerance statuses-a case-control study. PLoS One. doi: 10.1016/j.jacl.2017.12.011
2015;10(8):e0133640. 28. Gómez-Ambrosi J, Pascual-Corrales E, Catalán V, et al.
doi: 10.1371/journal.pone.0133640 Altered concentrations in dyslipidemia evidence a role for
ANGPTL8/betatrophin in lipid metabolism in humans.
18. Tseng YH, Yeh YH, Chen WJ, Lin KH. Emerging J Clin Endocrinol Metab. 2016;101(10):3803-3811.
regulation and function of betatrophin. IJMS. 2014;15(12):
23640-23657. doi: 10.1210/jc.2016-2084
doi: 10.3390/ijms151223640 29. Ye J, Qin Y, Wang D, Yang L, Yuan G. The relationship between
circulating ANGPTL8/betatrophin concentrations and adult
19. Sertogullarindan B, Komuroglu AU, Ucler R, Gunbatar H, obesity: A meta-analysis. Dis Markers. 2019;2019:5096860.
Sunnetcioglu A, Cokluk E. Betatrophin association with
serum triglyceride levels in obstructive sleep apnea patients. doi: 10.1155/2019/5096860
Ann Thorac Med. 2019;14(1):63-68. 30. Wu S, Gao H, Ma Y, Fu L, Zhang C, Luo X. Characterisation
doi: 10.4103/atm.ATM_52_18 of betatrophin concentrations in childhood and
adolescent obesity and insulin resistance. Pediatr Diabetes.
20. Xu F, Chen Y, Wang N, Sun K. Bacteria-derived recombinant 2016;17(1):53-60.
human ANGPTL8/betatrophin significantly increases the
level of triglyceride. Protein J. 2019;38(4):472-478. doi: 10.1111/pedi.12233
doi: 10.1007/s10930-019-09825-8 31. Guo K, Lu J, Yu H, et al. Serum betatrophin concentrations
are significantly increased in overweight but not in obese
21. Hassan AB, Salih SF, Hassan II, et al. Circulating betatrophin or type 2 diabetic individuals. Obesity (Silver Spring).
in relation to metabolic, inflammatory parameters, and 2015;23(4):793-797.
oxidative stress in patients with type 2 diabetes mellitus.
Diabetes Metab Syndr. 2019;13(1):458-463. doi: 10.1002/oby.21038
doi: 10.1016/j.dsx.2018.11.016 32. Wang H, Lai Y, Han C, et al. The effects of serum ANGPTL8/
betatrophin on the risk of developing the metabolic
22. Wang Y, Quagliarini F, Gusarova V, et al. Mice lacking syndrome – a prospective study. Sci Rep. 2016;6(1):28431.
ANGPTL8 (Betatrophin) manifest disrupted triglyceride
metabolism without impaired glucose homeostasis. Proc doi: 10.1038/srep28431
Natl Acad Sci USA. 2013;110(40):16109-16114. 33. Chen CC, Susanto H, Chuang WH, Liu TY, Wang CH.
doi: 10.1073/pnas.1315292110 Higher serum betatrophin level in type 2 diabetes subjects
is associated with urinary albumin excretion and renal
23. Fenzl A, Itariu BK, Kosi L, et al. Circulating betatrophin function. Cardiovasc Diabetol. 2016;15:3.
correlates with atherogenic lipid profiles but not with
glucose and insulin levels in insulin-resistant individuals. doi: 10.1186/s12933-015-0326-9
Diabetologia. 2014;57(6):1204-1208. 34. Pazgan-Simon M, Zuwala-Jagiello J, Menzyk T, et al. Serum
doi: 10.1007/s00125-014-3208-x betatrophin and irisin levels in hepatocellular carcinoma.
J Physiol Pharmacol. 2020;71(1): 113-123.
24. Hu H, Sun W, Yu S, et al. Increased circulating levels of
betatrophin in newly diagnosed type 2 diabetic patients. doi: 10.26402/jpp.2020.1.11
Diabetes Care. 2014;37:2718-2722.
35. Hong BS, Liu J, Zheng J, et al. Angiopoietin-like protein
doi: 10.2337/dc14-0602 8/betatrophin correlates with hepatocellular lipid content

Volume 9 Issue 2 (2025) 268 doi: 10.36922/EJMO025080034